CBS News (29 Mar 2023)
FDA approves overdose-reversing Narcan for over-the-counter sale
Comments on how OTC naloxone isn’t enough to address issues with access.
Read more
Privacy and Digital Health: Causes for Concern and a Way Forward
Check out our recent Journal of Addiction Medicine invited commentary
Bridge Michigan (25 July 2025)
Emphasizing cost-effective strategies is crucial to prevent the misuse of opioid settlement funds
New Research: Opioid Settlement Accountability
Understanding processes to report opioid settlement waste, fraud, abuse, & mismanagement to the AG
The Opioid Policy Institute Shuts Down
FOR IMMEDIATE RELEASE Date: May 2, 2025 Well, folks, pack it up. Turn off the lights, shred the research papers (save it for confetti though!), and cancel that subscription – the Opioid Policy Institute is officially closing, effective immediately. We’re closing because the laser-focused efforts by President Donald J. Trump